Private Eye

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Multiple insider buying at Microbix Biosystems (T:MBX)

Updated Thursday May 20, 2021 03:10 AM EDT

Joseph David Renner, a Director, acquired 666,667 Common Shares on a control or direction basis for registered holder Joe Renner family trust at a price of $0.600 through a prospectus or prospectus exempt offering on May 19th, 2021. The insider also acquired 333,333 Warrants with an exercise price of $0.800 for 24 months. This represents a $400,000 investment into the company's shares and an account share holdings change of greater than 100%.

Either other insiders also participated in the financing.

Microbix Biosystems is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Microbix Biosystems Inc is a Canada-based life science company and manufacturer of viral and bacterial antigens and cell, culture-based biological products and technologies. The Company has developed and acquired two technologies: Kinlytic Urokinase and LumiSort. Kinlytic Urokinase is a biologic thrombolytic drug used to treat blood clots. LumiSort is a technology for ultra-rapid and efficient sorting of somatic cells that can be used to enrich cell populations of interest. The Company's catalogue of antigens covers over 30 bacterial and viral pathogens that are implicated in maternal, pediatric, childhood, respiratory, sexually-transmitted and insect-borne diseases. Microbix Biosystems Inc. (MBX) has a high amount of executive buying compared to its small-cap peers in the market over the past three months. According to regulatory filings yesterday, nine insiders have invested a total amount of $686,000.

INK Edge Outlook

6 months ago
1 year ago
Mostly Sunny
The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at
Two-week free trial for first time users.
Go to Microbix Biosystems Inc. (MBX)'s company page

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).

Comment On!

No Comments


Search (past week) for $MBX.CA

  • No tweets found